FDA inspection
Planet Solutions: FDA inspection ending Mar 2, 2000
FDA inspection 16410 · Official Action Indicated (OAI) · Ft Lauderdale, FL
Key facts
| Inspection ID | 16410 |
|---|---|
| Firm | Planet Solutions |
| FEI number | 3002950096 |
| Address | 5601 Powerline Rd Ste 301 |
| City | Ft Lauderdale |
| State | FL |
| ZIP | 33309-2831 |
| Fiscal year | 2000 |
| Inspection end date | Mar 2, 2000 |
| Classification | Official Action Indicated (OAI) |
| Project area | OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs|Unapproved and Misbranded Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data